← Back to delvant.io

Tier 3 - Annual subscriptions

Audit-format intelligence on a fixed annual fee

Three subscription bands. Two to ten reports per year. Same evidence-tier methodology, same Gate A and Gate B pre-delivery checks as a one-off T1 or T2. The right fit when a medical affairs team or investor needs a recurring rhythm of scoped reports rather than ad-hoc procurement each time.

New to Delvant? Most first engagements are one-off: a Tier 1 report (EUR 3.5K-6.5K, ~1 week) or a Tier 2 (EUR 12K-35K, 2-3 weeks). Subscriptions are typically the second or third engagement, once the methodology has earned the cadence. See all four tiers.

Why a subscription, not always a one-off

Procurement clears once per year. Scope is agreed up-front against the asset, indication set, or fund thesis. New report requests do not need a fresh PO. The deliverable cadence is predictable; the price is predictable; the methodology is the same as Delvant T1 and T2.

T3 Lite

Two reports per year

EUR 18,000
Per year, billed annually
  • Two T1-scoped reports (10-15 pages each)
  • Scoped on demand against an agreed asset or indication
  • Standard turnaround (~1 week per report)
  • Evidence-tier methodology, Gate A and Gate B
  • EU AI Act Article 4 documentation per report
Scope T3 Lite
T3 Pro

Ten reports per year

EUR 80,000
Per year, billed annually
  • Ten reports per year (mix of T1 and T2 scope)
  • Quarterly 60-min review call on portfolio direction
  • Top priority queue
  • Evidence-tier methodology, Gate A and Gate B with two passes
  • Two scope-amendments per year at no extra fee
  • EU AI Act Article 4 documentation per report
  • Optional KOL probes on Pro-band requests
Scope T3 Pro

How T3 compares to one-off engagements

DimensionOne-off T1 / T2T3 Subscription
ProcurementNew PO per reportSingle annual PO
Scope agreementPer engagementOnce at contract, refreshed annually
Turnaround~1 week (T1) / 2-3 weeks (T2)Same, with priority queue on Std and Pro
MethodologyEvidence-tier, Gate A and Gate BSame, no compromise
Best forOne specific clinical or competitive questionRecurring portfolio coverage, multi-asset MA team, fund thesis tracking
Total annual costVariable, EUR 3.5-35K per reportPredictable, EUR 18K / 42K / 80K per year

Common procurement questions

Can the subscription scope change during the year?

Yes, within the agreed asset or indication set. T3 Standard includes one scope-amendment, T3 Pro includes two, at no extra fee. Larger pivots are scoped as a contract addendum.

What happens if we use fewer reports than the band allows?

Unused reports do not roll forward to the next contract year. The annual fee covers capacity reservation, not pure usage. This is by design: priority queue and dedicated scope assumptions require committed capacity.

What if we need an extra report beyond the band?

Subscribers get a 15% discount on additional reports beyond the band cap, billed at the same T1 or T2 unit price.

Is the methodology the same as T1 and T2?

Identical. Same evidence tiering (RCT / Indirect / RWE / Editorial / Underpowered / No data), same Gate A and Gate B pre-delivery checks, same EU AI Act Article 4 documentation per project. Subscription is a procurement vehicle, not a methodology compromise.

How do reports get triggered during the year?

Three options: standing topic schedule agreed at contract, ad-hoc scoping calls (15-30 min) per request, or a hybrid. Most subscribers use a hybrid: two anchor topics per year plus on-demand for the rest.

Who signs off on each report?

A named subscriber-side stakeholder is agreed at contract. They receive each Gate-B-signed PDF directly; no public posting, no third-party distribution without their permission.

Want to talk through whether a subscription fits?

A 30-minute scoping call before signing is included free for any prospective T3 subscriber. We will map your portfolio coverage needs against Lite, Standard, or Pro and confirm fit.

Book scoping call Email directly